
Eli Lilly has announced that CEO John Lechleiter is set to retire, with David Ricks to assume the role as …

John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …
German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …
Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug …

Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

